Author: Park, Jinsung; Shin, Dong Wook; Kim, Tae-Hwan; Jung, Seung Il; Nam, Jong Kil; Park, Seung Chol; Hong, Sungwoo; Jung, Jae Hung; Kim, Hongwook; Kim, Won Tae
Title: Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24 Document date: 2017_3_10
ID: 4pbwjlm3_36
Snippet: We acknowledge that our study has potential limitations. Follow-up rate was not optimal due to administrative failure in three institutes (responsible for 74% and 63.5% of not completing the questionnaire at visits 2 and 3, respectively), follow-up loss and patient refusal, which was attributable to various reasons including outbreak of Middle East Respiratory Syndrome during about half of our study period (from May 2015 to study end). However, b.....
Document: We acknowledge that our study has potential limitations. Follow-up rate was not optimal due to administrative failure in three institutes (responsible for 74% and 63.5% of not completing the questionnaire at visits 2 and 3, respectively), follow-up loss and patient refusal, which was attributable to various reasons including outbreak of Middle East Respiratory Syndrome during about half of our study period (from May 2015 to study end). However, because response rate was high (> 95% for non-sexual scales) in patients given the questionnaire, this finding does not mean that the module is not valid and difficult to understand. Despite possible limitations, given that majority of BC patients are diagnosed with NMIBC and no NMIBC-specific QOL questionnaire exists in Korea, the Korean version of QLQ-NMIBC24 module would be a useful tool to evaluate patient-reported outcomes in patients with NMIBC in clinical routine practice and in the research setting.
Search related documents:
Co phrase search for related documents- administrative failure and patient loss refusal: 1
- BC patient and study period: 1
- BC patient and useful tool: 1
- clinical routine practice and end study: 1, 2, 3
- clinical routine practice and research setting: 1
- clinical routine practice and response rate: 1, 2, 3, 4
- clinical routine practice and routine practice: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical routine practice and study period: 1, 2, 3, 4, 5
- clinical routine practice and useful tool: 1, 2, 3
- end study and follow rate: 1, 2
- end study and patient report: 1
- end study and questionnaire complete: 1, 2
- end study and research setting: 1
- end study and response rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- end study and routine practice: 1, 2, 3, 4, 5
- end study and study period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- end study and study period half: 1
- end study and useful tool: 1, 2
- follow rate and patient loss: 1
Co phrase search for related documents, hyperlinks ordered by date